| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human METRNL recombinant protein (Position: K66-D311) was used as the immunogen for the METRNL antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
METRNL Antibody / Meteorin-like protein is a anti-METRNL Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), ELISA with listed reactivity in Human.
Key elements and design rationale
- Target: METRNL
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, ELISA
Biological background
Functionally, METRNL antibody identifies a 311-amino-acid secreted protein expressed in skeletal muscle, adipose tissue, and immune cells. METRNL is released during exercise and cold exposure, stimulating IL4-dependent macrophage activation that enhances energy expenditure and tissue remodeling. It also supports nerve regeneration and angiogenesis in damaged tissues.
The METRNL gene is located on chromosome 17q25.3 and encodes a protein structurally related to Meteorin (METRN). Its expression is induced by PGC1-alpha and STAT6 pathways, linking metabolic and immune regulation. METRNL functions as an intercellular communicator coordinating metabolic adaptation and immune homeostasis.
Pathologically, dysregulated METRNL expression is associated with metabolic disorders, obesity, and inflammation. Increased METRNL levels correlate with improved insulin sensitivity and energy balance, while reduced expression is linked to chronic inflammation and fibrosis. Research using METRNL antibody supports studies in metabolism, immunology, and regenerative biology.
METRNL antibody is suitable for ELISA, western blotting, and immunohistochemistry to detect circulating and tissue-localized Meteorin-like protein.
Structurally, Meteorin-like protein contains a conserved alpha-helical fold characteristic of secreted growth factors. Its glycosylation and secretion signal peptide facilitate stable extracellular function. This antibody enables detailed study of METRNL's dual roles in metabolic control and immune modulation.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
